By Siddhi Mahatole June 26 (Reuters) - The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today ...

Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of ...

Viridian Therapeutics said the U.S. Food and Drug Administration has approved Lumvoa to treat thyroid eye disease. The company said it will launch Lumvoa immediately, adding physicians can begin ...

By Kunal Das and Sneha S K June 24 (Reuters) - Texas-based biotech Ollin Biosciences said on Wednesday it has raised $330 ...

Share on Pinterest An experimental CRISPR-based gene editing treatment significantly improved vision outcomes in subjects with a rare eye disorder. Robert Nickelsberg/Getty Images Researchers from ...

Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new eye drop formulation for treating dry eye disease. The team reports in ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues. Ocular manifestation of ...

A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment while ...

Researchers describe the work as a proof of concept that opens the possibility of harnessing the ocular microbiome to treat ...